Publication: Should MitraClip be preferred over surgery in high-risk patients with severe MR and CKD?
Loading...
Program
KU-Authors
Organization Authors
Co-Authors
Marmagkiolis, Kostas
Date
Language
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Severe mitral regurgitation (MR) may lead to worsening renal function due to a decrease in stroke volume, increase in systemic vascular resistance, and venous pooling. Percutaneous treatment with MitraClip seems to improve renal function in certain patient groups. Larger studies are needed to prove that MitraClip is the preferred strategy in patients with severe MR and chronic kidney disease.
Source
Publisher
Wiley
Subject
Citation
item.page.haspartof
Source
Catheterization and Cardiovascular Interventions
item.page.ispartofseries
item.page.edition
DOI
10.1002/ccd.25887
item.page.datauri
item.page.link
Rights
N/A
Copyrights Note
Rights and licensing
N/A
